clinical trial · NCT06868264
C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
HEPATITIS C VIRUS CHRONIC INFECTIONBemnifosbuvir-Ruzasvir (BEM/RZR)Sofosbuvir-Velpatasvir (SOF/VEL)
brief summary
The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.
started
Apr 7, 2025
primary completion
Sep 1, 2026
completion
Dec 1, 2026
last updated
Dec 5, 2025
official title
Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed-dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination (SOF/VEL FDC) in Subjects With Chronic Hepatitis C Virus (HCV) Infection
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol